These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21692905)

  • 1. An open label clinical trial of complement inhibition in multifocal motor neuropathy.
    Fitzpatrick AM; Mann CA; Barry S; Brennan K; Overell JR; Willison HJ
    J Peripher Nerv Syst; 2011 Jun; 16(2):84-91. PubMed ID: 21692905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A smooth transition protocol for patients with multifocal motor neuropathy going from intravenous to subcutaneous immunoglobulin therapy: an open-label proof-of-concept study.
    Misbah SA; Baumann A; Fazio R; Dacci P; Schmidt DS; Burton J; Sturzenegger M
    J Peripher Nerv Syst; 2011 Jun; 16(2):92-7. PubMed ID: 21692906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy.
    Hahn AF; Beydoun SR; Lawson V; ; Oh M; Empson VG; Leibl H; Ngo LY; Gelmont D; Koski CL
    J Peripher Nerv Syst; 2013 Dec; 18(4):321-30. PubMed ID: 24725024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy.
    Chaudhry V; Cornblath DR
    J Peripher Nerv Syst; 2010 Sep; 15(3):196-201. PubMed ID: 21040141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg.
    Rüegg SJ; Fuhr P; Steck AJ
    Neurology; 2004 Dec; 63(11):2178-9. PubMed ID: 15596777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
    Gorson KC; Natarajan N; Ropper AH; Weinstein R
    Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New liquid intravenous immunoglobulin (10 % IVIg) for treatment of multifocal motor neuropathy: a prospective study of efficacy, safety and tolerability.
    Cats EA; van der Pol WL; Piepers S; Notermans NC; van den Berg-Vos RM; van den Berg LH
    J Neurol; 2008 Oct; 255(10):1598-9. PubMed ID: 18758888
    [No Abstract]   [Full Text] [Related]  

  • 8. Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.
    Rother RP; Rollins SA; Mojcik CF; Brodsky RA; Bell L
    Nat Biotechnol; 2007 Nov; 25(11):1256-64. PubMed ID: 17989688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Elebute M; Kelly R; Urbano-Ispizua A; Hill A; Rother RP; Khursigara G; Fu CL; Omine M; Browne P; Rosse W
    Am J Hematol; 2010 Aug; 85(8):553-9. PubMed ID: 20658586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous IgG for treatment of neuromuscular diseases].
    Vedeler CA; Mellgren SI; Omdal R; Torbergsen T; Aasly J
    Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1717-20. PubMed ID: 20835282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulins in chronic inflammatory demyelinating polyneuropathy.
    Comi G; Quattrini A; Fazio R; Roveri L
    Neurol Sci; 2003 Oct; 24 Suppl 4():S246-50. PubMed ID: 14598053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do A-waves help predict intravenous immunoglobulin response in multifocal motor neuropathy without block?
    Lange DJ; Nijjar R; Voustianiouk A; Seidel G; Panchal J; Wang AK
    Muscle Nerve; 2011 Apr; 43(4):537-42. PubMed ID: 21305570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi-center, open-label, 52-week phase 3 trial.
    Kuwabara S; Misawa S; Mori M; Iwai Y; Ochi K; Suzuki H; Nodera H; Tamaoka A; Iijima M; Toda T; Yoshikawa H; Kanda T; Sakamoto K; Kusunoki S; Sobue G; Kaji R;
    J Peripher Nerv Syst; 2018 Jun; 23(2):115-119. PubMed ID: 29635876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short and long-term effect of IVIg in demyelinating neuropathy associated with MGUS, experience of a monocentric study.
    Théaudin M; Lozeron P; Lacroix C; Chrétien P; Ducot B; Denier C; Adams D
    Rev Neurol (Paris); 2011 Dec; 167(12):897-904. PubMed ID: 22023823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improvement of severe and intravenous immunoglobulin-dependent multifocal motor neuropathy with conduction block after long-term rituximab].
    Michaud A; Delmont E; Jeandel PY; Desnuelle C
    Rev Neurol (Paris); 2011 Dec; 167(12):916-20. PubMed ID: 21752414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN.
    Piepers S; Jansen MD; Cats EA; van Sorge NM; van den Berg LH; van der Pol WL
    J Neuroimmunol; 2010 Dec; 229(1-2):256-62. PubMed ID: 20920831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.
    Halstead SK; Zitman FM; Humphreys PD; Greenshields K; Verschuuren JJ; Jacobs BC; Rother RP; Plomp JJ; Willison HJ
    Brain; 2008 May; 131(Pt 5):1197-208. PubMed ID: 18184663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial.
    Harbo T; Andersen H; Hess A; Hansen K; Sindrup SH; Jakobsen J
    Eur J Neurol; 2009 May; 16(5):631-8. PubMed ID: 19236457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria.
    Dmytrijuk A; Robie-Suh K; Cohen MH; Rieves D; Weiss K; Pazdur R
    Oncologist; 2008 Sep; 13(9):993-1000. PubMed ID: 18784156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
    Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
    J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.